HA-pseudotyped retroviral vectors for influenza antagonist screening

Journal of Biomolecular Screening

Volumn 14, Issue 3, 2009, Pages 294-302

  Wang, Shi Yun ^a   Su, Ching Yao ^a,b   Lin, Mengi ^a   Huang, Shao Yung ^a   Huang, Wen I ^a   Wang, Cheng Chi ^a,b   Wu, Ying Ta ^a   Cheng, Ting Jen R ^a   Yu, Hui Ming ^a   Ren, Chien Tai ^a   Wu, Chung Yi ^a   Wong, Chi Huey ^a,b   Cheng, Yih Shyun E ^a  

^a GENOMICS RESEARCH CENTER   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Antiviral; Hemagglutinin; HTS; Influenza; Pseudotype virus

Indexed keywords

GALACTOSE; HEMAGGLUTININ; OLIGOSACCHARIDE; RETROVIRUS VECTOR;

ARTICLE; CONTROLLED STUDY; ENZYME BINDING; HUMAN; HUMAN CELL; INFLUENZA; INFLUENZA VIRUS A H5N1; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; VESICULAR STOMATITIS; VIRUS INHIBITION;

ANIMALS; ANTIVIRAL AGENTS; CELL LINE; CELL LINE, TUMOR; DOGS; DRUG EVALUATION, PRECLINICAL; GENES, REPORTER; GENETIC VECTORS; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H5N1 SUBTYPE; KIDNEY; LUCIFERASES; LUNG NEOPLASMS; PLASMIDS; RECOMBINANT PROTEINS; RETROVIRIDAE; TRANSDUCTION, GENETIC; TRANSFECTION; VIRUS REPLICATION;

AVES; ORTHOMYXOVIRIDAE;

EID: 63849282953     PISSN: 10870571     EISSN: 1552454X     Source Type: Journal    
DOI: 10.1177/1087057108330786     Document Type: Article

References (27)

1. Sorrell EM, Ramirez-Nieto GC, Gomez-Osorio IG, Perez DR: Genesis of pandemic influenza. Cytogenet Genome Res 2007 ; 117: 394-402.
2. Lipatov AS, Govorkova EA, Webby RJ, Ozaki H., Peiris M., Guan Y., et al. Influenza: emergence and control. J Virol 2004 ; 78: 8951-8959.
3. de Wit E., Fouchier RA: Emerging influenza. J Clin Virol 2008 ; 41: 1-6.
4. Poland GA, Jacobson RM, Targonski PV: Avian and pandemic influenza: an overview. Vaccine 2007 ; 25: 3057-3061.
5. Skehel JJ, Wiley DC: Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu Rev Biochem 2000 ; 69: 531-569.
6. Steinhauer DA: Role of hemagglutinin cleavage for the pathogenicity of influenza virus. Virology 1999 ; 258: 1-20.
7. Yamada S., Suzuki Y., Suzuki T., Le MQ, Nidom CA, Sakai-Tagawa Y., et al. Haemagglutinin mutations responsible for the binding of H5N1 influenza A viruses to human-type receptors. Nature 2006 ; 444: 378-382.
8. Stevens J., Blixt O., Glaser L., Taubenberger JK, Palese P., Paulson JC, et al. Glycan microarray analysis of the hemagglutinins from modern and pandemic influenza viruses reveals different receptor specificities. J Mol Biol 2006 ; 355: 1143-1155.
9. Gambaryan A., Tuzikov A., Pazynina G., Bovin N., Balish A., Klimov A.: Evolution of the receptor binding phenotype of influenza A (H5) viruses. Virology 2006 ; 344: 432-438.
10. Barclay WS, Jones IM, Osborn MI, Phillipson L., Ren J., Talevera GA, et al. Probing the receptor interactions of H5 avian influenza virus using a baculovirus expression system and functionalized poly(acrylic acid) ligands. Bioorg Med Chem 2007 ; 15: 4038-4047.
11. Meisner J., Szretter KJ, Bradley KC, Langley WA, Li ZN, Lee BJ, et al. Infectivity studies of influenza virus hemagglutinin receptor binding site mutants in mice. J Virol 2008 ; 82: 5079-5083.
12. Nicholls JM, Chan MC, Chan WY, Wong HK, Cheung CY, Kwong DL, et al. Tropism of avian influenza A (H5N1) in the upper and lower respiratory tract. Nat Med 2007 ; 13: 147-149.
13. Hota S., McGeer A.: Antivirals and the control of influenza outbreaks. Clin Infect Dis 2007 ; 45: 1362-1368.
14. Hayden FG, Pavia AT: Antiviral management of seasonal and pandemic influenza. J Infect Dis 2006 ; 194 (suppl 2). S119 - S126.
15. De Clercq E.: Antiviral agents active against influenza A viruses. Nat Rev Drug Discov 2006 ; 5: 1015-1025.
16. Barr IG, Hurt AC, Iannello P., Tomasov C., Deed N., Komadina N.: Increased adamantane resistance in influenza A(H3) viruses in Australia and neighbouring countries in 2005. Antiviral Res 2007 ; 73: 112-117.
17. Rahman M., Bright RA, Kieke BA, Donahue JG, Greenlee RT, Vandermause M., et al. Adamantane-resistant influenza infection during the 2004-05 season. Emerg Infect Dis 2008 ; 14: 173-176.
18. Yen HL, Ilyushina NA, Salomon R., Hoffmann E., Webster RG, Govorkova EA: Neuraminidase inhibitor-resistant recombinant A/Vietnam/1203/04 (H5N1) influenza viruses retain their replication efficiency and pathogenicity in vitro and in vivo. J Virol 2007 ; 81: 12418-12426.
19. Su CY, Wang SY, Shie JJ, Jeng KS, Temperton NJ, Fang JM, et al. In vitro evaluation of neuraminidase inhibitors using the neuraminidase-dependent release assay of hemagglutinin-pseudotyped viruses. Antiviral Res 2008 ; 79: 199-205.
20. Fedorko DP, Nelson NA, McAuliffe JM, Subbarao K.: Performance of rapid tests for detection of avian influenzaA virus types H5N1 and H9N2. J Clin Microbiol 2006 ; 44: 1596-1597.
21. Jones JC, Turpin EA, Bultmann H., Brandt CR, Schultz-Cherry S.: Inhibition of influenza virus infection by a novel antiviral peptide that targets viral attachment to cells. J Virol 2006 ; 80: 11960-11967.
22. Gamblin SJ, Haire LF, Russell RJ, Stevens DJ, Xiao B., Ha Y., et al. The structure and receptor binding properties of the 1918 influenza hemagglutinin. Science 2004 ; 303: 1838-1842.
23. Temperton NJ, Hoschler K., Major D., Nicolson C., Manvell R., Hien VM, et al. A sensitive retroviral pseudotype assay for influenza H5N1-neutralizing antibodies. Influenza Other Respir Viruses 2007 ; 1: 105-112.
24. Otsego N., Ishida H., Kiso M., Hasegawa A.: Synthesis of sialyl Lax ganglioside analogues modified at C-6 of the galactose residue to elucidate the mechanism of selection recognition. Carbohydr Res 1998 ; 306: 517-530.
25. Komba S., Ishida H., Kiso M., HasegawaA.: Synthesis of sialyl Le(x) ganglioside analogues sulfated at C-6 of either the galactose or N-acetylglucosamine residues, and at both of the galactose and N-acetylglucosamine residues: probes for clarifying the real carbohydrate ligand of L-selectin. Carbohydr Res 1996 ; 285: C1 - C8.
26. Hasegawa A., Kato M., Ando T., Ishida H., Kiso M.: Synthesis of sialyl Lewis X ganglioside analogues containing modified L-fucose residues. Carbohydr Res 1995 ; 274: 165-181.
27. Blixt O., Head S., Mondala T., Scanlan C., Huflejt ME, Alvarez R., et al. Printed covalent glycan array for ligand profiling of diverse glycan binding proteins. Proc Natl Acad Sci USA 2004 ; 101: 17033-17038.